F Lalloo
F Lalloo
Manchester Centre for Genomic Medicine
Verified email at mft.nhs.uk
Cited by
Cited by
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani, JS Reis-Filho, L Fulford, F Penault-Llorca, M van der Vijver, ...
Clinical cancer research 11 (14), 5175-5180, 2005
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ...
Gut 62 (6), 812-823, 2013
Birth incidence and prevalence of tumor‐prone syndromes: estimates from a UK family genetic register service
DG Evans, E Howard, C Giblin, T Clancy, H Spencer, SM Huson, F Lalloo
American journal of medical genetics Part A 152 (2), 327-332, 2010
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ...
British journal of cancer 98 (8), 1457-1466, 2008
Germline mutations in RAD51D confer susceptibility to ovarian cancer
C Loveday, C Turnbull, E Ramsay, D Hughes, E Ruark, JR Frankum, ...
Nature genetics 43 (9), 879-882, 2011
Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD
CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ...
Human mutation 31 (1), 41-51, 2010
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
E Amir, DG Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, ...
Journal of medical genetics 40 (11), 807-814, 2003
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, ...
Clinical genetics 75 (2), 141-149, 2009
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS genetics 9 (3), e1003212, 2013
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO
DGR Evans, DM Eccles, N Rahman, K Young, M Bulman, E Amir, ...
Journal of medical genetics 41 (6), 474-480, 2004
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
A Moran, C O’hara, S Khan, L Shack, E Woodward, ER Maher, F Lalloo, ...
Familial cancer 11 (2), 235-242, 2012
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Familial breast cancer
F Lalloo, DG Evans
Clinical genetics 82 (2), 105-114, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
E Ruark, K Snape, P Humburg, C Loveday, I Bajrami, R Brough, ...
Nature 493 (7432), 406-410, 2013
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction
AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ...
Cancer research 70 (23), 9742-9754, 2010
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer …
DG Evans, A Shenton, E Woodward, F Lalloo, A Howell, ER Maher
BMC cancer 8 (1), 1-9, 2008
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
The system can't perform the operation now. Try again later.
Articles 1–20